VeriMombarley sh-oligopeptide-1은 임신 중 안전한가요?
No evidence of reproductive or developmental hazard was identified in authoritative sources. There is no harmonised CLP classification (ECHA Annex VI) for reproductive toxicity for 'barley sh-oligopeptide-1', no SCCS or CIR safety assessment flagging reproductive risk, and no peer‑reviewed reports of teratogenicity or endocrine disruption in PubMed. Peptides of this type are large biomolecules with low systemic absorption after topical application, so exposure is expected to be negligible for pregnancy.
성분
barley sh-oligopeptide-1
알려진 위험 없음100
/100
0
Pregnancy-safe products containing barley sh-oligopeptide-1
Related ingredients
Frequently asked questions
- barley sh-oligopeptide-1은 임신 중 안전한가요?
- No evidence of reproductive or developmental hazard was identified in authoritative sources. There is no harmonised CLP classification (ECHA Annex VI) for reproductive toxicity for 'barley sh-oligopeptide-1', no SCCS or CIR safety assessment flagging reproductive risk, and no peer‑reviewed reports of teratogenicity or endocrine disruption in PubMed. Peptides of this type are large biomolecules with low systemic absorption after topical application, so exposure is expected to be negligible for pregnancy.
- barley sh-oligopeptide-1은 모유 수유 중 안전한가요?
- No data indicate reproductive or lactation hazards. No harmonised classification or authoritative safety assessment (CIR/SCCS) indicates risk to breastfeeding; no peer‑reviewed evidence shows milk transfer or effects on lactation. Topical peptides are unlikely to achieve systemic levels sufficient to transfer into breast milk.
- barley sh-oligopeptide-1은 아기 피부에 안전한가요?
- No evidence of developmental or dermal toxicity in infants. Mechanistic concerns are not documented. However, infants (0–3 yr) have a higher skin permeability and higher surface‑area‑to‑weight ratio, so exposure potential is higher than in adults; adult dermal absorption for large oligopeptides is expected to be negligible, but given immature barrier function a conservative exposure score of 1 is applied. No infant‑specific adverse reports were found.
- VeriMom은 barley sh-oligopeptide-1을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 barley sh-oligopeptide-1을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 barley sh-oligopeptide-1 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.